Obesity Drugs Insights, Diabetes Trials, and Walking for Back Pain

In this episode, Dr. Chi-Ming Chow begins with an introduction to the day's topics. The discussion kicks off with Amycretin, a new drug for weight management, and insights into trial results. Dr. Chow then explores potential side effects of obesity drugs, sharing expert opinions. The focus shifts to semaglutide, examining its promising results in trials for Type 1 diabetes and concerns regarding its safety and off-label use. The episode also addresses the reevaluation of "high-risk" labels in sexual health. Additionally, Dr. Chow discusses the benefits of walking for reducing chronic lower back pain, offering expert recommendations. The episode concludes with Dr. Chow's closing remarks.